Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Potent peripheral benzodiazepine receptor ligand is effective in mouse model of RA

Jan. 25, 2000

Novel COX-2 inhibitors obtained through conversion of NSAIDs

Jan. 25, 2000

Antiinflammatory factor identified in glucocorticoid-treated human monocytes

Jan. 24, 2000

Thienodipyridines useful for inflammatory and immune disorders designed at Takeda

Jan. 24, 2000

Pfizer patents new series of COX-2 inhibitors with sulfonybenzene structure

Jan. 21, 2000

Selective inhibitors of alpha4 integrin binding for inflammatory, immune disorders

Jan. 21, 2000

New antiinflammatory agents from HMR (Aventis) act by inhibiting cell adhesion

Jan. 18, 2000

Vertex patents heterocyclic p38 MAP kinase inhibitors and their use

Jan. 17, 2000

Esteve presents new COX-2 inhibitor and pharmacological profile

Jan. 14, 2000

Vertex continues to pursue therapeutically active p38 MAP kinase inhibitors

Jan. 14, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...